{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:17:36Z","timestamp":1776212256738,"version":"3.50.1"},"reference-count":23,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The interaction of posaconazole and amphotericin B was evaluated in concomitant treatment of\n            <jats:italic>Candida albicans<\/jats:italic>\n            systemic infections in immunocompetent mice by using four strains of\n            <jats:italic>C. albicans<\/jats:italic>\n            with different susceptibilities to fluconazole. Posaconazole and amphotericin B were each tested at four dose levels alone and in all possible combinations against each\n            <jats:italic>C. albicans<\/jats:italic>\n            strain. Survival curves of mice treated with combinations of posaconazole and amphotericin B were statistically compared with those of mice treated with the component monotherapies. Of the 64 total combinations evaluated against the\n            <jats:italic>C. albicans<\/jats:italic>\n            strains (16 combinations per strain), 20.3% were more effective in prolonging mouse survival than both of the monotherapies, 45.3% were more effective than one of the monotherapies, and 32.8% were similar to both monotherapies. No evidence of antagonism was observed between posaconazole and amphotericin B in this mouse model, consistent with in vitro results against the same strains.\n          <\/jats:p>","DOI":"10.1128\/aac.49.2.638-642.2005","type":"journal-article","created":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T22:04:40Z","timestamp":1106777080000},"page":"638-642","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":22,"title":["Interaction between Posaconazole and Amphotericin B in Concomitant Treatment against\n            <i>Candida albicans<\/i>\n            In Vivo"],"prefix":"10.1128","volume":"49","author":[{"given":"Anthony","family":"Cacciapuoti","sequence":"first","affiliation":[{"name":"Schering-Plough Research Institute, Kenilworth, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Gurnani","sequence":"additional","affiliation":[{"name":"Schering-Plough Research Institute, Kenilworth, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Halpern","sequence":"additional","affiliation":[{"name":"Schering-Plough Research Institute, Kenilworth, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Norris","sequence":"additional","affiliation":[{"name":"Schering-Plough Research Institute, Kenilworth, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Patel","sequence":"additional","affiliation":[{"name":"Schering-Plough Research Institute, Kenilworth, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Loebenberg","sequence":"additional","affiliation":[{"name":"Schering-Plough Research Institute, Kenilworth, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.9.1721"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.11.2541"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.922-926.2001"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.1.137-142.2004"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2435-2441.2000"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.1.64"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2017-2022.2000"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/infdis\/168.3.692","volume":"168","year":"1993","unstructured":"George, D., D. Kordick, P. Miniter, T. Patterson, and V. T. Andriole. 1993. Combination therapy in experimental invasive aspergillosis. J. Infect. Dis.168:692-698.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.10.3208-3214.2002"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.12.2831"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.12.2841"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.485-494.2001"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.758-764.2004"},{"key":"e_1_3_2_15_2","unstructured":"National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M27-A. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_16_2","unstructured":"National Research Council. 1996. NIH guide to the care and use of laboratory animals. National Academy Press Washington D.C."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.727-731.2000"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.6.1345"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/376524"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.8.1669"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.2.371"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.3.598"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.9.1907"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1086\/515319","volume":"177","year":"1998","unstructured":"Sugar, A. M., and X-P. Liu. 1998. Interactions of itraconazole with amphotericin B in the treatment of murine invasive candidiasis. J. Clin. Infect. Dis.177:1660-1663.","journal-title":"J. Clin. Infect. Dis."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.2.638-642.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.49.2.638-642.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:47:32Z","timestamp":1645469252000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.49.2.638-642.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1128\/AAC.49.2.638-642.2005"],"URL":"https:\/\/doi.org\/10.1128\/aac.49.2.638-642.2005","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"2004-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-09-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}